High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.
about
High-throughput sequencing of immune repertoires in multiple sclerosisNovel technologies and emerging biomarkers for personalized cancer immunotherapyMinimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesMaking the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantationBeyond model antigens: high-dimensional methods for the analysis of antigen-specific T cellsNext generation sequencing: new tools in immunology and hematologyAdvancing the Minimal Residual Disease Concept in Acute Myeloid LeukemiaIntegrative network modeling approaches to personalized cancer medicineA bioinformatic framework for immune repertoire diversity profiling enables detection of immunological statusVDJviz: a versatile browser for immunogenomics data.Digital genomic quantification of tumor-infiltrating lymphocytes.Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence.Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.Next generation MRD.Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.Unifying immunology with informatics and multiscale biology.Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing.Characterizing immune repertoires by high throughput sequencing: strategies and applications.Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.Comprehensive analysis of the T-cell receptor beta chain gene in rhesus monkey by high throughput sequencingIMSEQ--a fast and error aware approach to immunogenetic sequence analysis.Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient.VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia.A Public Database of Memory and Naive B-Cell Receptor SequencesClinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use.Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.Measurements of treatment response in childhood acute leukemia.High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology.Molecular and genetic inflammation networks in major human diseases.Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing.The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis.Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes.Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia.Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemiaClinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation.
P2860
Q26747682-5804B170-3A63-40B9-A071-240367B802B8Q26770780-2D142A04-1A70-4446-A195-5669B75FBDF2Q26828511-32CE48FE-FEA1-4445-970D-7F83AD718EA6Q27002964-D73F4015-99EF-4EF1-8078-CA6E70F6DC2EQ27013972-309D7F2C-B173-4DCC-8DF6-AB298C61BA1AQ27025231-68DF562F-F530-47D2-B54B-282E0B0CC0B9Q28087291-00B6F97D-7F61-4C89-8CA5-DFBE5C231272Q28602016-21F35DE0-E8AE-4E3D-94E5-3CACDE1555D6Q28647646-E5D18F6E-EF5C-4F4C-B5E1-513F3E37230DQ31107890-8D273F89-0773-4995-8791-033360E813F2Q33631158-2D138B81-F8E7-4727-8492-C9BB30C8258BQ34249667-E0EB5C38-5A44-4B47-BC19-9BD80BCD384BQ34364350-06D7E275-EC13-4039-B9CF-BA922CB7D0ECQ34406955-441298DF-B79A-4D82-ACD5-86E2F78D6E66Q34559389-F01C6D4D-5B5E-4520-80C1-7B1BAA724E15Q35134186-CD128B8B-0E3A-4A02-894D-62DA43F39E10Q35178180-97124523-31DF-4107-8C11-58CC2AAFA266Q35327599-6E5EBDC7-537B-497E-9A32-15457A6D9B09Q35377918-35E5F1C4-BC7D-433F-9A27-28EE4FF43E3AQ35591194-BC30EB9D-A570-4286-B228-A21BEC950851Q35634815-68D0D1C5-2FC3-433C-BCA5-CEAAC60D5E70Q35751259-3D0026C8-C55B-4789-9F3A-A97FE0E968BFQ35852353-5CBECB17-A599-47B5-BEA8-EF65C51B971BQ36093798-5A972F64-DF42-4867-8D8E-783CA54DC3D6Q36101141-121F2688-3346-4878-A0C4-09016F67EB7CQ36182008-CC3D43A7-2505-49A2-900B-B06EB7C01440Q36183310-67488069-00A3-4B6F-AD48-4D6FDF3EF828Q36509641-CB82AC2B-F5C1-450B-B867-170AC6E91636Q36513773-3BD17D48-A3A6-4010-9498-D409ADA491B8Q36983736-ACAAA429-2D96-425A-AEBF-77598899D2CDQ37114392-3E504251-77D7-4C29-9B05-513F4FE8DD94Q37307811-41843B74-A7DA-4524-AA68-291496225100Q37346110-B51FFE00-DCE1-405F-9BB4-CD182BB37771Q37390232-473EEF37-2B79-4606-B485-A2FC525E06A4Q37481981-A464B227-D245-46D4-9A51-AF873999237AQ37601706-A1712C95-5911-4B4D-A15E-2D4FC819278AQ37619915-07488721-6987-4BF6-B567-40FCD31EB10BQ38028808-E0E7CA8B-0DB3-461C-B744-B3287F10CD88Q38068816-CFB00BE6-A7E6-4014-ACA8-24EED7909B9DQ38105123-D4B84A28-8686-4012-A48F-797EA658E671
P2860
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
High-throughput sequencing det ...... cute T lymphoblastic leukemia.
@en
High-throughput sequencing det ...... cute T lymphoblastic leukemia.
@nl
type
label
High-throughput sequencing det ...... cute T lymphoblastic leukemia.
@en
High-throughput sequencing det ...... cute T lymphoblastic leukemia.
@nl
prefLabel
High-throughput sequencing det ...... cute T lymphoblastic leukemia.
@en
High-throughput sequencing det ...... cute T lymphoblastic leukemia.
@nl
P2093
P2860
P1476
High-throughput sequencing det ...... cute T lymphoblastic leukemia.
@en
P2093
Anna Sherwood
Brent L Wood
Daniel E Sabath
Harlan Robins
Harvey A Greisman
Jonathan R Fromm
Mignon L Loh
Stuart S Winter
P2860
P304
P356
10.1126/SCITRANSLMED.3003656
P407
P577
2012-05-01T00:00:00Z